These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 8502273)
1. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. Friedman SL N Engl J Med; 1993 Jun; 328(25):1828-35. PubMed ID: 8502273 [No Abstract] [Full Text] [Related]
2. [Pathophysiology of hepatic fibrosis]. Vaĺková M Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583 [TBL] [Abstract][Full Text] [Related]
4. Mediators of hepatic fibrogenesis. Gressner AM Hepatogastroenterology; 1996; 43(7):92-103. PubMed ID: 8682491 [No Abstract] [Full Text] [Related]
5. A cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver. Gressner AM; Chunfang G Verh Dtsch Ges Pathol; 1995; 79():1-14. PubMed ID: 8600672 [TBL] [Abstract][Full Text] [Related]
6. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutical targets for revert liver fibrosis]. García B L; Gálvez G J; Armendáriz B J Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907 [TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells and the reversal of fibrosis. Kisseleva T; Brenner DA J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681 [TBL] [Abstract][Full Text] [Related]
13. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm. Gressner AM; Bachem MG Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677 [TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis: from the bench to clinical targets. Pinzani M; Rombouts K Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333 [TBL] [Abstract][Full Text] [Related]
15. [Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis]. Gressner AM Med Klin (Munich); 1987 Oct; 82(20):700-10. PubMed ID: 3316964 [No Abstract] [Full Text] [Related]
17. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis]. Casu A; Canepa M; Nanni G Pathologica; 1994 Oct; 86(5):467-99. PubMed ID: 7739873 [TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells as a target for the treatment of liver fibrosis. Bataller R; Brenner DA Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471 [TBL] [Abstract][Full Text] [Related]
20. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Winwood PJ; Arthur MJ Semin Liver Dis; 1993 Feb; 13(1):50-9. PubMed ID: 8446908 [No Abstract] [Full Text] [Related] [Next] [New Search]